Single-center, Open-label, Randomized 2-way Crossover Study of the Effect of Lacosamide 200 mg Twice Daily on the Single-dose Pharmacokinetics and Pharmacodynamics of Warfarin (25 mg) in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Lacosamide (Primary) ; Warfarin
- Indications Epilepsy; Fibromyalgia; Osteoarthritis; Pain; Thromboembolism
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors UCB Pharma Inc
- 23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.
- 04 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2012 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History